查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404686

美国家庭输液治疗市场规模、份额、趋势分析报告：按产品、按应用、细分市场预测，2024-2030 年

U.S. Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-Infective, Endocrinology), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 116 Pages | 商品交期: 2-10个工作天内

价格

美国家庭输液治疗市场的成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，美国家庭输液治疗市场预计将达到 318 亿美元。

预计2024年至2030年该市场将以7.7%的复合年增长率扩张。老年人口的增加和癌症、免疫力缺乏、克隆氏症、感染疾病、脱水、营养缺乏、多发性硬化症、噁心和呕吐等疾病盛行率的增加正在显着推动市场成长。缩短住院时间的需求不断增长以及老年人口中慢性病盛行率的上升正在推动成长。

院内感染（HAI）的增加也是预测期内推动美国家庭输液治疗产业成长的主要因素。根据美国疾病管制与预防中心的数据，每年约有 170 万名住院患者感染医疗保健获得性感染疾病(HCAI)，约 98,000 人（每 17 名患者中就有 1 人）死于感染疾病。为此，家庭输液治疗的需求大幅增加。

这一趋势正在增加家庭输液治疗的技术创新，例如将电子健康记录与医疗设备和输液帮浦结合。电子健康记录允许储存、搜寻和修改医疗记录，使医疗保健专业人员和患者更容易追踪特定疾病的改善情况。

越来越多的患者更喜欢家庭医疗保健，因为与住院相比更具成本效益，这为行业参与者推出更多创新产品提供了机会。此外，更安全产品的推出最终将有助于美国家庭输液治疗市场的成长。由于COVID-19的出现，该国的家庭输液主要企业已被活化。这一趋势预计将进一步提振市场，因为该国众多医疗机构预计将永久选择居家输液服务，以减轻医院和其他医疗机构的病患入院负担。

美国家庭输液治疗市场报告亮点

  • 与其他部门相比，输液帮浦部门占据了最大的销售份额，因为它用于提供所需量的营养物质、药物和其他必要的输液，因此效率不断提高。
  • 无针连接器市场预计将快速成长，因为它具有各种优点，例如细菌污染风险较小和对针刺伤害的保护更高。
  • 由于抗感染剂在居家医疗中广泛用作抗真菌药物、抗生素和抗病毒药物，因此抗感染药物在 2023 年占据了最大的收益占有率。
  • 由于甲状腺和糖尿病等与内分泌系统相关的疾病的增加，内分泌领域预计将成为成长最快的领域。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国家庭输液治疗市场：細項分析，依产品，2018-2030

  • 2023 年及 2030 年产品市场占有率分析
  • 美国家庭输液治疗市场（按产品），2023-2030 年
  • 2023-2030年市场规模、预测及趋势分析

第四章美国家庭输液治疗市场：依应用細項分析，2018-2030

  • 2023 年和 2030 年应用市场占有率分析
  • 美国家庭输液治疗市场（按应用），2023-2030
  • 2023年至2030年市场规模、预测与趋势分析

第 5 章 家庭输液治疗市场：2018-2030 年各国市场

  • 2023-2030年市场规模、预测与趋势分析
  • 美国

第六章家庭输液治疗市场-竞争分析

  • Competitive Dashboard Analysis-Impact Analysis
    • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类（主要创新者、市场领导、新兴参与者）
    • 主要创新者名单
    • 市场领导者名单
    • 新晋球员名单
  • 公司市场分析（收益、产品系列、主要服务业、主要联盟）
    • 按收益
  • Strategy Framework
  • 公司简介
    • B. Braun Melsungen AG
    • Baxter
    • Caesarea Medical Electronics
    • CareFusion Corporation
    • Fresenius Kabi AG
    • ICU Medical, Inc.
    • JMS Co., Ltd.
    • Smiths Medical
    • Terumo Corporation
    • Coram LLC
    • Option Care Enterprises, Inc.
    • BioScrip, Inc.
    • BriovaRx Infusion Services
    • Paragon Healthcare, Inc.
Product Code: GVR-3-68038-956-2

U.S. Home Infusion Therapy Market Growth & Trends:

The U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 7.7% from 2024 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market's growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients' preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

U.S. Home Infusion Therapy Market Report Highlights:

  • The infusion pumps segment held the largest revenue share compared to others due to the increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
  • The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
  • The anti-infective segment held the maximum revenue share in 2023 owing to its extensive use as an antifungal, antibiotic, and antiviral agent at home care
  • Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 Objectives
    • 1.8.1 Objective 1
    • 1.8.2 Objective 2
    • 1.8.3 Objective 3
    • 1.8.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Penetration & Growth Prospect Mapping
  • 2.3 Market Dynamics
    • 2.3.1 Market driver analysis
      • 2.3.1.1 Increasing geriatric population
      • 2.3.1.2 Rising prevalence of chronic disorders
      • 2.3.1.3 Rapid technological advancements
      • 2.3.1.4 Growing incidence of hospital-acquired infections
      • 2.3.1.5 Home healthcare as a cost-effective alternative
    • 2.3.2 Market restrain analysis
      • 2.3.2.1 Presence of complicated reimbursement framework and reimbursement cuts
    • 2.3.3 Impact Of The 21st Century Cures Act And Projections For The Impact Of The Bipartisan Budget Act Of 2018.
    • 2.3.4 Trends For Home Infusion For Medicare Part B And Medicare Part D
  • 2.4 U.S. Home Infusion Therapy: Market Analysis Tools
    • 2.4.1 Industry analysis - Porter's
    • 2.4.2 PESTLE analysis
  • 2.5 U.S Home Infusion Therapy- Company Market Share Analysis 2023
  • 2.6 Major Deals & Strategic Alliances Analysis
  • 2.7 Procedure cost analysis/breakdown
  • 2.8 Technology Timeline
  • 2.9 Regulatory Framework
  • 2.10 Reimbursement framework

Chapter 3 U.S Home Infusion Therapy Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 3.1 Product Market Share Analysis, 2023 & 2030
  • 3.2 U.S. Home Infusion Therapy Market, by Product, 2023 to 2030
  • 3.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 3.3.1 Infusion pumps
      • 3.3.1.1 Infusion Pumps Market, 2018 - 2030 (USD Million)
      • 3.3.1.2 Elastomeric Market, 2018 - 2030 (USD Million)
      • 3.3.1.3 Electromechanical Market, 2018 - 2030 (USD Million)
      • 3.3.1.4 Gravity Market, 2018 - 2030 (USD Million)
      • 3.3.1.5 Others Market, 2018 - 2030 (USD Million)
    • 3.3.2 Intravenous sets
    • 3.3.3 Intravenous Sets Market, 2018 - 2030 (USD Million)
    • 3.3.4 Gravity Sets Market, 2018 - 2030 (USD Million)
    • 3.3.5 Dedicated Sets Market, 2018 - 2030 (USD Million)
    • 3.3.6 IV Cannulas
      • 3.3.6.1 IV Cannulas Market, 2018 - 2030 (Usd Million)
    • 3.3.7 Needleless Connectors
      • 3.3.7.1 Needleless Connectors Market, 2018 - 2030 (USD Million)

Chapter 4 U.S. Home Infusion Therapy Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1 Application Market Share Analysis, 2023 & 2030
  • 4.2 U.S. Home Infusion Therapy Market, by Application, 2023 to 2030
  • 4.3 Market Size & Forecasts and Trend Analyses, 2023 to 2030
    • 4.3.1 Anti-Infective
      • 4.3.1.1 Anti-infective market, 2018 - 2030 (USD Million)
    • 4.3.2 endocrinology
      • 4.3.2.1 ENDOCRINOLOGY MARKET, 2018 - 2030 (USD Million)
      • 4.3.2.2 Diabetes market, 2018 - 2030 (USD Million)
      • 4.3.2.3 Others market, 2018 - 2030 (USD Million)
    • 4.3.3 Hydration therapy
      • 4.3.3.1 hydration therapy market, 2018 - 2030 (USD Million)
      • 4.3.3.2 Athletes market, 2018 - 2030 (USD Million)
      • 4.3.3.3 Others market, 2018 - 2030 (USD Million)
    • 4.3.4 Chemotherapy
      • 4.3.4.1 CHEMOTHERAPY MARKET, 2018 - 2030 (USD Million)
    • 4.3.5 Enteral nutrition
      • 4.3.5.1 ENTERAL NUTRITION market, 2018 - 2030 (USD Million)
    • 4.3.6 Parenteral nutrition
      • 4.3.6.1 PARENTERAL NUTRITION market, 2018 - 2030 (USD Million)
    • 4.3.7 Specialty pharmaceuticals
      • 4.3.7.1 SPECIALTY PHARMACEUTICALS MARKET, 2018 - 2030 (USD Million)
    • 4.3.8 Others
      • 4.3.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Home Infusion Therapy Market: Country Market Analysis, By Product, 2018 - 2030 (USD Million)

  • 5.1 Market Size, & Forecasts and Trend Analysis, 2023 to 2030
  • 5.2 U.S.
    • 5.2.1 U.S. Home Infusion Therapy market, by product, 2018 - 2030 (USD Million)
    • 5.2.2 U.S. Home Infusion Therapy market, by Appliction, 2018 - 2030 (USD Million)

Chapter 6 Home Infusion Therapy Market - Competitive Analysis

  • 6.1 Competitive Dashboard Analysis - Impact Analysis
    • 6.1.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
    • 6.2.1 List of key innovators
    • 6.2.2 List of market leader
    • 6.2.3 List of emerging players
  • 6.3 Company market position analysis (Revenue, product portfolio, key serviceable industries, key alliances)
    • 6.3.1 By Revenue
  • 6.4 Strategy Framework
  • 6.5 Company Profiles
    • 6.5.1 B. Braun Melsungen AG
      • 6.5.1.1 Company overview
      • 6.5.1.2 Financial performance
      • 6.5.1.3 Product benchmarking
      • 6.5.1.4 Strategic initiatives
    • 6.5.2 Baxter
      • 6.5.2.1 Company overview
      • 6.5.2.2 Financial performance
      • 6.5.2.3 Product benchmarking
      • 6.5.2.4 Strategic initiatives
    • 6.5.3 Caesarea Medical Electronics
      • 6.5.3.1 Company overview
      • 6.5.3.2 Product benchmarking
      • 6.5.3.3 Strategic initiatives
    • 6.5.4 CareFusion Corporation
      • 6.5.4.1 Company overview
      • 6.5.4.2 Financial performance
      • 6.5.4.3 Product benchmarking
      • 6.5.4.4 Strategic initiatives
    • 6.5.5 Fresenius Kabi AG
      • 6.5.5.1 Company overview
      • 6.5.5.2 Financial performance
      • 6.5.5.3 Product benchmarking
      • 6.5.5.4 Strategic initiatives
    • 6.5.6 ICU Medical, Inc.
      • 6.5.6.1 Company overview
      • 6.5.6.2 Financial performance
      • 6.5.6.3 Product benchmarking
      • 6.5.6.4 Strategic initiatives
    • 6.5.7 JMS Co., Ltd.
      • 6.5.7.1 Company overview
      • 6.5.7.2 Financial performance
      • 6.5.7.3 Product benchmarking
    • 6.5.8 Smiths Medical
      • 6.5.8.1 Company overview
      • 6.5.8.2 Financial performance
      • 6.5.8.3 Product benchmarking
      • 6.5.8.4 Strategic initiatives
    • 6.5.9 Terumo Corporation
      • 6.5.9.1 Company overview
      • 6.5.9.2 Financial performance
      • 6.5.9.3 Product benchmarking
      • 6.5.9.4 Strategic initiatives
    • 6.5.10 Coram LLC
      • 6.5.10.1 Company overview
      • 6.5.10.2 Product benchmarking
    • 6.5.11 Option Care Enterprises, Inc.
      • 6.5.11.1 Company overview
      • 6.5.11.2 Financial performance
      • 6.5.11.3 Product benchmarking
      • 6.5.11.4 Strategic initiatives
    • 6.5.12 BioScrip, Inc.
      • 6.5.12.1 Company overview
      • 6.5.12.2 Financial performance
      • 6.5.12.3 Product benchmarking
      • 6.5.12.4 Strategic initiatives
    • 6.5.13 BriovaRx Infusion Services
      • 6.5.13.1 Company overview
      • 6.5.13.2 Financial performance
      • 6.5.13.3 Product benchmarking
      • 6.5.13.4 Strategic initiatives
    • 6.6.14 Paragon Healthcare, Inc.
      • 6.6.14.1 Company overview
      • 6.6.14.2 Financial performance
      • 6.6.14.3 Product benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Home Infusion Therapy market, leading market players per region
  • Table 3 U.S. Home Infusion Therapy market, Regional Network Map
  • Table 4 U.S. Home Infusion Therapy market, market differentiating factor

List of Figures

  • Fig. 1 U.S. home infusion therapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 U.S. population over 60 years by age, 1900 - 2050
  • Fig. 13 Prevalence of chronic disease in the U.S.
  • Fig. 14 Treatment cost by healthcare setting (Average cost per day in USD)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 PESTLE analysis
  • Fig. 18 U.S. Home Infusion Therapy market: Company market share analysis, 2023
  • Fig. 19 U.S. Home Infusion Therapy market: Company market share analysis, 2023
  • Fig. 20 U.S. Home Infusion Therapy Market: Product movement analysis
  • Fig. 21 U.S. Home Infusion Therapy Market Product Outlook: Key takeaways
  • Fig. 22 Infusion pumps market, 2018 - 2030 (USD Million)
  • Fig. 23 Elastomeric market, 2018 - 2030 (USD Million)
  • Fig. 24 Electromechanical market, 2018 - 2030 (USD Million)
  • Fig. 25 Gravity market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Intravenous sets market, 2018 - 2030 (USD Million)
  • Fig. 28 Intravenous sets market, 2018 - 2030 (USD Million)
  • Fig. 29 Dedicated sets market, 2018 - 2030 (USD Million)
  • Fig. 30 IV cannulas market, 2018 - 2030 (USD Million)
  • Fig. 31 Needleless connectors market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. home infusion therapy market: Application movement analysis
  • Fig. 33 Home infusion therapy market application outlook: Key takeaways
  • Fig. 34 Anti-infective market, 2018 - 2030 (USD Million)
  • Fig. 35 Endocrinology market, 2018 - 2030 (USD Million)
  • Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
  • Fig. 37 Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Hydration therapy market, 2018 - 2030 (USD Million)
  • Fig. 39 Athletes market, 2018 - 2030 (USD Million)
  • Fig. 40 Others market, 2018 - 2030 (USD Million)
  • Fig. 41 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 42 Enteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 43 Parenteral nutrition market, 2018 - 2030 (USD Million)
  • Fig. 44 Specialty pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Country Dynamics
  • Fig. 47 Recent Developments & Impact Analysis
  • Fig. 48 Strategy Framework